Predictors of the course of idiopathic generalized epilepsy with grand mal seizures

被引:2
|
作者
Runge, U
Haufe, A
Kessler, C
机构
[1] Department of Neurology, Ernst Moritz Arndt Univ. of G., Greifswald
[2] Department of Neurology, Ernst Moritz Arndt University, 17487 Greifswald
来源
JOURNAL OF EPILEPSY | 1996年 / 9卷 / 03期
关键词
idiopathic generalized epilepsy; grand mal seizures; prognosis; patient compliance; antiepileptic drugs; predictors;
D O I
10.1016/0896-6974(96)00024-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We wished to determine the predictors of the clinical course of idiopathic generalized epilepsy with grand mal seizures (IGE). We studied 70 patients with IGE. Patient information was statistically evaluated with regard to its prognostic relevance. Forty-four (63%) of the patients were seizure-free, eight despite poor compliance. Of the 26 patients who continued to experience seizures, 22 had poor compliance, and four patients did not receive the optimal dose of antiepileptic drugs (AEDs). The decisive factor in achieving seizure freedom was appropriate antiepileptic drug (AED) therapy with good compliance. The following factors were unrelated to the course of the epilepsy: sex, age at onset, duration of epilepsy, combination of different seizure types or the sequence with which various types developed, time of day during which seizures occurred, the number of seizures, and time elapsed between the first occurrence of seizures and initiation of drug treatment. Eight patients were seizure-free without AED therapy, which suggests spontaneous remission in the course of IGE. From our results, we conclude that optimal therapy with good compliance is the critical predictor for the course of IGE.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 50 条
  • [1] Idiopathic generalized epilepsy presenting with hemiconvulsive seizures
    Kiley, MA
    Smith, SJM
    Sander, JW
    EPILEPSIA, 2000, 41 (12) : 1633 - 1636
  • [2] Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy
    Kenyon, Katharine
    Mintzer, Scott
    Nei, Maromi
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (03): : 234 - 236
  • [3] Idiopathic generalized epilepsies with pure grand mal: clinical data and genetics
    Unterberger, I
    Trinka, E
    Luef, G
    Bauer, G
    EPILEPSY RESEARCH, 2001, 44 (01) : 19 - 25
  • [4] Chronic management of seizures in the syndromes of idiopathic generalized epilepsy
    Bourgeois, BFD
    EPILEPSIA, 2003, 44 : 27 - 32
  • [5] Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial
    French, Jacqueline A.
    Krauss, Gregory L.
    Wechsler, Robert T.
    Wang, Xue-Feng
    DiVentura, Bree
    Brandt, Christian
    Trinka, Eugen
    O'Brien, Terence J.
    Laurenza, Antonio
    Patten, Anna
    Bibbiani, Francesco
    NEUROLOGY, 2015, 85 (11) : 950 - 957
  • [6] Predictors of the course of illness in patients with cryptogenic focal epilepsy with complex partial seizures
    Runge, U
    JOURNAL OF EPILEPSY, 1996, 9 (03): : 176 - 183
  • [7] A course of idiopathic generalized epilepsy in adult and elderly patients
    Perunova, NY
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2005, 105 (03): : 4 - 6
  • [8] Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy
    Rohracher, Alexandra
    Brigo, Francesco
    Hoefler, Julia
    Kalss, Gudrun
    Neuray, Caroline
    Dobesberger, Judith
    Kuchukhidze, Giorgi
    Leitinger, Markus
    Trinka, Eugen
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1403 - 1411
  • [9] Exceptional response to brivaracetam in a patient with refractory idiopathic generalized epilepsy and absence seizures
    Grande-Martin, Alberto
    Sopelana-Garay, David
    Manuel Pardal-Fernandez, Jose
    Maria Sanchez-Honrubia, Rosa
    Abelardo Sanchez-Larsen, Alvaro
    EPILEPTIC DISORDERS, 2018, 20 (01) : 60 - 64
  • [10] Integrating electrodermal biofeedback into pharmacologic treatment of grand mal seizures
    Scrimali, Tullio
    Tomasello, Damiana
    Sciuto, Massimo
    FRONTIERS IN HUMAN NEUROSCIENCE, 2015, 9